참고문헌
- Barret M, Antoun S, Dalban C, et al (2014). Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer, 66, 583-9. https://doi.org/10.1080/01635581.2014.894103
- Chen LK, Liu LK, Woo J, et al (2014). Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc, 15, 95-101. https://doi.org/10.1016/j.jamda.2013.11.025
- Christensen JF, Jones LW, Andersen JL, et al (2014). Muscle dysfunction in cancer patients. Ann Oncol, 25, 947-58. https://doi.org/10.1093/annonc/mdt551
- Comte A, Huillard O, Biau D, et al (2014). Sarcopenia and acute severe toxicity in sarcoma patients treated wtih doxorubicinbased chemotherapy. Ann Oncol, 25, 504-5.
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al (2010). Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39, 412-23. https://doi.org/10.1093/ageing/afq034
- Harimoto N, Shirabe K, Yamashita YI, et al (2013). Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg, 100, 1523-30. https://doi.org/10.1002/bjs.9258
- Hayashi T, Kamachi K, Kazuno A, Ito E, Chino O, Shimada H, et al (2014). Impact of sarcopenia on long-term prognosis of patients with esophageal cancer after surgery. J Clin Oncol, 32, 118.
- Jung HW, Kim JW, Kim JY, et al (2015). Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer, 23, 687-94. https://doi.org/10.1007/s00520-014-2418-6
- Kim TN, Choi KM (2013). Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab, 20, 1-10. https://doi.org/10.11005/jbm.2013.20.1.1
- Luciani A, Gilda A, Tagliabue L, et al (2008). The impact of chemotherapy on sarcopenia and fatigue in elderly cancer patients: A prospective pilot study. J Clin Oncol, 26, 9635. https://doi.org/10.1200/jco.2008.26.15_suppl.9635
- Otsuji H, Yokoyama Y, Ebata T, et al (2015). Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg, 39, 1494-500. https://doi.org/10.1007/s00268-015-2988-6
- Prado CM, Baracos VE, McCargar LJ, et al (2009). Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res, 15, 2920-6. https://doi.org/10.1158/1078-0432.CCR-08-2242
- Prado CM, Lieffers JR, McCargar LJ, et al (2008). Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol, 9, 629-35. https://doi.org/10.1016/S1470-2045(08)70153-0
- Psutka SP, Carrasco A, Schmit GD, et al (2014). Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer, 120, 2910-8. https://doi.org/10.1002/cncr.28798
- Stene GB, Helbostad JL, Amundsen T, et al (2015). Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncol, 54, 340-8. https://doi.org/10.3109/0284186X.2014.953259
- Villasenor A, Ballard-Barbash R, Baumgartner K, et al (2012). Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv, 6, 398-406. https://doi.org/10.1007/s11764-012-0234-x
피인용 문헌
- Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis vol.8, pp.6, 2017, https://doi.org/10.1002/jcsm.12212
- Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy vol.14, pp.2, 2017, https://doi.org/10.3892/ol.2017.6287
- Prevalence of Sarcopenia and Its Relationship with Nutritional State and Quality of Life in Patients with Digestive Diseases vol.64, pp.6, 2018, https://doi.org/10.3177/jnsv.64.445